The global Non-Clinical CRO Services market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

ReportPrime's newest research report, the “Non-Clinical CRO Services Industry Forecast” looks at past sales and reviews total world Non-Clinical CRO Services sales in 2022, providing a comprehensive analysis by region and market sector of projected Non-Clinical CRO Services sales for 2023 through 2029. With Non-Clinical CRO Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-Clinical CRO Services industry.

This Insight Report provides a comprehensive analysis of the global Non-Clinical CRO Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Non-Clinical CRO Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Non-Clinical CRO Services market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-Clinical CRO Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-Clinical CRO Services.

The United States market for Non-Clinical CRO Services is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Non-Clinical CRO Services is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Non-Clinical CRO Services is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Non-Clinical CRO Services players cover:

• CMIC Group
• Shanghai Innostar Biotech
• ApconiX
• Charles River Laboratories
• ERBC Group

In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Non-Clinical CRO Services market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Safety Pharmacology Testing
• Administration Toxicity Test
• Reproductive Toxicity Test
• Genotoxicity Test
• Immunogenicity Studies
• Carcinogenicity Test
• Other

Segmentation by Application:

• Pharmaceutical Center
• Institute
• Hospital

This report also splits the market by region:

1. Americas
   • United States
   • Canada
   • Mexico
   • Brazil
2. APAC
   • China
   • Japan
   • Korea
   • Southeast Asia
   • India
   • Australia
3. Europe
   • Germany
   • France
   • UK
   • Italy
   • Russia
4. Middle East & Africa
   • Egypt
   • South Africa
   • Israel
   • Turkey
   • GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration:

• CMIC Group
• Shanghai Innostar Biotech
• ApconiX
• Charles River Laboratories
• ERBC Group
• STILLMEADOW
• ICON